Healix (503B Compounding Pharmacy Services Division) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Healix (503B Compounding Pharmacy Services Division) General Information
Description
Provider of compounded sterile preparation services. The company provides high-quality, ready-to-use compounded sterile preparations to hospitals across the country through its manufacturing facility that is registered with the U.S. Food and Drug Administration (FDA) as an Outsourcing Facility under Section 503B of the Federal Food, Drug, and Cosmetic Act.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 14140 Southwest Freeway
- Suite 400
- Sugar Land, TX 77478
- United States
Healix (503B Compounding Pharmacy Services Division) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Healix (503B Compounding Pharmacy Services Division) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|